Opass Putcharoen, MD,MSc

Assistant Professor
Division of Infectious Disease, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Thailand

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-569) Changes in lipid profile in people living with HIV on stable protease inhibitors (PIs)-based regimens as second-line ART regimens switch to dolutegravir (DTG)-based regimens
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-580) A randomized controlled trial evaluating virologic and renal outcomes after switching from TDF/FTC/EFV to TDF/3TC/DTG (TLD) versus DTG+3TC in virologically suppressed Thai PWH – a pilot study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-2067) Antibody Response in People Living with HIV on Effective ART: A Comparison of CD4 T-cell counts >200 versus ≤200 cells/mm³ Following a Bivalent mRNA COVID-19 Vaccine Booster, with Evaluation of the Correlation Between Anti-RBD IgG (Anti-Receptor Binding Domain Immunoglobulin) and sVNT (SARS-CoV-2 Surrogate Virus Neutralization Test).
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT

• (P-2344) Genomic Analysis of Monkeypox Virus (MPVX) Outbreak in Bangkok, Thailand in 2022-2023
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT